The Atlanta Journal-Constitution
CDC: PREPARE FOR VACCINE SOON
Possible rollout of two candidates could arrive as early as late October.
The CDC has notified states to prepare to distribute a coronavirus vaccine as soon as late October or November,
The Centers for Disease Control and Prevention has notified public health officials in all 50 states and five large cities to prepare to distribute a coronavirus vaccine to health care workers and other high-risk groups as soon as late October or early November.
The new CDC guidance is the latest sign of an accelerating race for a vaccine to greatly ease a pandemic that has killed more than 184,000 Americans. The documents were sent out on the same day that President Donald Trump told the nation in his speech to the Republican National Convention that a vaccine might arrive before the end of the year.
Over the past week, both Dr. Anthony Fauci, the country’s top infectious disease expert, and Dr. Stephen Hahn, who heads the Food and Drug Administration, have said a vaccine could be available for certain groups before clinical trials have been completed, if the data are overwhelmingly positive.
Public health experts agree that agencies at all levels of government should urgently prepare for what will eventually be a vast, complex effort to vaccinate hundreds of millions of Americans. But the possibility of a rollout in late October or early November has also heightened concerns that the Trump administration is seeking to rush the distribution of a vaccine — or simply to hype that one is possible — before Election Day on Nov. 3.
The CDC plans lay out technical specifications for two candidates described as “Vaccine A” and “Vaccine B,” including requirements for shipping, mixing, storage and administration. The details seem to match the products developed by Pfizer and Moderna, which are the furthest along in late-stage clinical trials. On Aug. 20, Pfizer said it was “on track” for seeking government review “as early as October 2020.”
“This timeline of the initial deployment at the end of October is deeply worrisome for the politicization of public health and the potential safety ramifications,” said Saskia Popescu, an infection prevention epidemiologist based in Arizona. “It’s hard not to see this as a push for a pre-election vaccine.”
Three documents were sent to public health officials in all states and territories as well as New York,
Chicago, Philadelphia, Houston and San Antonio on Aug. 27. They outlined detailed scenarios for distributing two unidentified vaccine candidates.
The guidance noted that health care professionals, including longterm care employees, would be among the first to receive the product, along with other essential workers and national security employees. People 65 or older, as well as those from “racial and ethnic minority populations,” Native Americans and incarcerated individuals — all communities known to be at greater risk of contracting the virus and experiencing severe disease — were also prioritized in the documents.